<p>Infosys on Thursday said it has signed a definitive agreement to acquire Kaleidoscope Innovation, a full-spectrum product design, development and insights firm innovating across medical, consumer and industrial markets, bolstering capabilities in the design of smart products, for an undisclosed sum.</p>.<p>Kaleidoscope Innovation brings to Infosys a diverse talent pool with knowledge of design and engineering. The company leverages an understanding of clinical environments, product development capabilities across domains, and a consultancy-style approach addressing human factors, product design, UI/UX design, research & insight, development and visualisation, the company said in a statement.</p>.<p>It serves a diversified customer base with in-house labs, 3D design environments and customer experience centres. Kaleidoscope designs microsurgical instruments, devices used in minimally invasive surgery, drug delivery devices for ophthalmic therapies and user-centric wearables. It also offers usability testing in support of regulatory submissions, including the delivery mechanism for aortic stents.</p>.<p>Ravi Kumar, President, Infosys, said, “This acquisition further strengthens our digital offerings at the intersection of new software technologies and medical devices - a sector that is expected to witness significant investments and consumerisation in the post-Covid era."</p>.<p>The acquisition is expected to close during the second quarter of fiscal 2021, subject to customary closing conditions.</p>
<p>Infosys on Thursday said it has signed a definitive agreement to acquire Kaleidoscope Innovation, a full-spectrum product design, development and insights firm innovating across medical, consumer and industrial markets, bolstering capabilities in the design of smart products, for an undisclosed sum.</p>.<p>Kaleidoscope Innovation brings to Infosys a diverse talent pool with knowledge of design and engineering. The company leverages an understanding of clinical environments, product development capabilities across domains, and a consultancy-style approach addressing human factors, product design, UI/UX design, research & insight, development and visualisation, the company said in a statement.</p>.<p>It serves a diversified customer base with in-house labs, 3D design environments and customer experience centres. Kaleidoscope designs microsurgical instruments, devices used in minimally invasive surgery, drug delivery devices for ophthalmic therapies and user-centric wearables. It also offers usability testing in support of regulatory submissions, including the delivery mechanism for aortic stents.</p>.<p>Ravi Kumar, President, Infosys, said, “This acquisition further strengthens our digital offerings at the intersection of new software technologies and medical devices - a sector that is expected to witness significant investments and consumerisation in the post-Covid era."</p>.<p>The acquisition is expected to close during the second quarter of fiscal 2021, subject to customary closing conditions.</p>
